...
首页> 外文期刊>Prenatal Diagnosis >Prenatal sonographic diagnosis of autosomal recessive polycystic kidney disease (ARPKD) during the early second trimester.
【24h】

Prenatal sonographic diagnosis of autosomal recessive polycystic kidney disease (ARPKD) during the early second trimester.

机译:孕中期早期常染色体隐性多囊肾疾病(ARPKD)的产前超声诊断。

获取原文
获取原文并翻译 | 示例
           

摘要

Autosomal recessive polycystic kidney disease (ARPKD) is a rare hereditary disease with a high neonatal mortality. Currently, prenatal diagnosis is possible only during the second half of pregnancy, when bilaterally enlarged, echogenic kidneys are visible by ultrasound. We describe a case in which a diagnosis of ARPKD was sought in the first half of pregnancy. High-resolution ultrasonography revealed echogenic, normal-sized kidneys at 15 + 4 weeks. Microsatellite DNA analysis of a chorionic villus sample, parental blood, and blood of an affected sibling showed that the fetus had the maternal haplotype and a recombination of the paternal haplotype. Thus, no distinction between homo- and heterozygosity for the ARPKD mutation in the fetus was possible. A further ultrasound examination at 19 + 4 weeks confirmed the previous results, indicating that the fetus was likely to be affected. After termination of the pregnancy, the diagnosis was confirmed on microscopic examination.
机译:常染色体隐性隐性多囊肾病(ARPKD)是一种罕见的遗传性疾病,新生儿死亡率很高。目前,只有在妊娠的下半年才可以进行产前诊断,当双侧扩大时,可以通过超声看到回声的肾脏。我们描述了在怀孕的前半期寻求ARPKD诊断的病例。高分辨率超声检查显示15 + 4周回声正常大小的肾脏。绒毛膜绒毛样品,亲本血液和患病兄弟姐妹的血液的微卫星DNA分析表明,胎儿具有母体单倍型和父本单倍型的重组。因此,不可能对胎儿的ARPKD突变进行纯合和杂合。在19 + 4周时进行的进一步超声检查证实了先前的结果,表明胎儿可能受到了影响。妊娠终止后,通过显微镜检查确认诊断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号